✦ LIBER ✦

Relapse Prevention in Schizophrenia and Schizoaffective Disorder with Risperidone Long-Acting Injectable vs Quetiapine: Results of a Long-Term, Open-Label, Randomized Clinical Trial

✍ Scribed by Gaebel, Wolfgang; Schreiner, Andreas; Bergmans, Paul; de Arce, Rosario; Rouillon, Frédéric; Cordes, Joachim; Eriksson, Lars; Smeraldi, Enrico

Book ID: 121812797
Publisher: Nature Publishing Group
Year: 2010
Tongue: English
Weight: 486 KB
Volume: 35
Category: Article
ISSN: 1470-634X
DOI: 10.1038/npp.2010.111

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

P03-21 Relapse prevention in schizophren

P03-21 Relapse prevention in schizophrenia and schizoaffective disorder with risperidone long-acting injectable versus quetiapine: Randomized, long-term, open-label, clinical trial results (ConstaTRE)

✍ Gaebel, W.; Bergmans, P.; de Arce, R.; Rouillon, F.; Cordes, J.; Eriksson, L.; S 📂 Article 📅 2009 🏛 Elsevier Science 🌐 French ⚖ 46 KB

RELAPSE PREVENTION WITH RISPERIDONE LONG

RELAPSE PREVENTION WITH RISPERIDONE LONG-ACTING INJECTABLE VS. ORAL QUETIAPINE. RESULTS OF AN OPEN-LABEL RCT

✍ Wolfgang Gaebel 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 68 KB

P03-22 Long-term remission in schizophre

P03-22 Long-term remission in schizophrenia and schizoaffective disorder: Results from the risperidone long-acting injectable versus quetiapine relapse prevention trial (ConstaTRE)

✍ Smeraldi, E.; Cavallaro, R.; Smalc, V. Folnegovic; Bidzan, L.; Ceylan, E.; Schre 📂 Article 📅 2009 🏛 Elsevier Science 🌐 French ⚖ 48 KB

P03-24 Functional recovery in schizophre

P03-24 Functional recovery in schizophrenia and schizoaffective disorder: Results from the risperidone long-acting injectable versus quetiapine relapse prevention trial (ConstaTRE)

✍ Rouillon, F.; Eriksson, L.; Burba, B.; Raboch, J.; Kaprinis, G.; Schreiner, A. 📂 Article 📅 2009 🏛 Elsevier Science 🌐 French ⚖ 44 KB

AN OPEN, RANDOMIZED, CONTROLLED COMPARIS

AN OPEN, RANDOMIZED, CONTROLLED COMPARISON OF LONG-ACTING INJECTABLE RISPERIDONE VS. ORAL OLANZAPINE IN SCHIZOPHRENIA & SCHIZOAFFECTIVE DISORDER

✍ Nicholas A. Keks 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 68 KB

Safety and efficacy of long-acting injec

Safety and efficacy of long-acting injectable risperidone in patients with schizophrenia spectrum disorders: A 6-month open-label trial in Asian patients

✍ Swapna Verma; Mythily Subramaniam; Edimansyah Abdin; Kang Sim; Alex Su; Nelson L 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 104 KB 👁 2 views

## Abstract The study aimed to evaluate the efficacy of long‐acting injectable risperidone (LAR) in Asian patients with schizophrenia spectrum disorders. Twenty‐five patients enrolled in this 6‐month open labelled study. They were switched from their current antipsychotic to LAR without a prior or